Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMWG.L Regulatory News (MWG)

  • There is currently no data for MWG

AGM Statement

25 Apr 2018 07:00

RNS Number : 9663L
Modern Water PLC
25 April 2018
 

25 April 2018

 

Modern Water plc ("Modern Water" or "the Company")

 

AGM Statement

 

At today's Annual General Meeting of Modern Water Plc, the owner of leading technologies for water and wastewater treatment and for the monitoring of water quality, Alan Wilson, Non-Executive Chairman, will make the following statement:

 

"Modern Water has started 2018 strongly with Group revenue in the first-quarter 37% higher than in the same period last year. Both Divisions are performing well, with China the primary driver for the Monitoring Division and the Advance Works Contract for the Gibraltar waste-water treatment plant boosting the Membrane Division.

 

Gross profit in the first quarter was 40% higher than 2017 and Group overhead was 8% lower than the same period last year. The Group's cash position as of 20thof April 2018, stood at £343,000 and the finance facility ($600,000) secured on Modern Water Inc's receivables remained un-utilised.

 

Outlook

Management is confident that the strategic decision to terminate the contract of our sole Chinese distributor and pursue a multi-channel sales approach in one of our most important markets, was correct and first-quarter financial results clearly support that. We expect further progress in the remainder of 2018 and for the Monitoring Division is expected to return to EBITDA breakeven for the year.

 

In the Membrane Division, our principal process engineer is currently on site in India overseeing the final commissioning of our first full-scale All Membrane Brine Concentrator (AMBC). Two further paid-for trials with other industrial customers have been successful. We are also well-positioned in China and our first AMBC project is due to be commissioned shortly. With reference AMBC plants operational in both our key markets, we expect to see an acceleration of licence sales for this product during 2018.

 

The Gibraltar Advance Works Contract is progressing well and we remain committed to helping HM Government of Gibraltar to achieve its goal of completing the Waste Water Treatment Plant in 2020."

 

---Ends---

For further information:

 

Modern Water plc

+44 1483 696 000

Simon Humphrey, Chief Executive Officer

WH Ireland Limited

+44 207 220 1666

Chris Fielding (Nominated Adviser)

Tavistock

+44 207 920 3150

Andrew Dunn

James Collins

 

Notes to editors

Modern Water owns, installs and operates broad based membrane systems using world-leading Forward Osmosis (FO) membrane technologies; supplies packaged seawater Reverse Osmosis (RO) desalination systems; supplies wastewater treatment solutions; and develops and supplies advanced systems for water monitoring. Its shares trade on AIM.

 

Modern Water's patented forward osmosis (FO) technology's benefits include lower energy consumption and a reduction in environmental impact in a variety of industries. With a sales presence in almost 60 countries, the Group's Monitoring Division includes a leading real-time continuous toxicity monitor and trace metal analysers for monitoring the quality of drinking water.

www.modernwater.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEADLLAEDPEFF
Date   Source Headline
2nd Jun 20202:59 pmRNSExercise of Warrants
26th May 20207:00 amRNSSichuan China orders c£0.4m of Modern Water units
20th May 202010:32 amRNSModern Water Microtox LX declared winner in China
15th May 20201:57 pmRNSHolding(s) in Company
13th May 20204:41 pmRNSSecond Price Monitoring Extn
13th May 20204:36 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSFirst Modern Water wastewater AMBC order for India
12th May 20209:05 amRNSSecond Price Monitoring Extn
12th May 20209:00 amRNSPrice Monitoring Extension
11th May 20204:40 pmRNSSecond Price Monitoring Extn
11th May 20204:35 pmRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
11th May 20207:00 amRNSMicrotoxLX Finalist in China Lab Instrument Award
6th May 20202:05 pmRNSSecond Price Monitoring Extn
6th May 20202:01 pmRNSPrice Monitoring Extension
6th May 20209:00 amRNSPrice Monitoring Extension
6th May 20207:00 amRNSProduction Update
17th Apr 20204:40 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSIncrease in Orders for Reagent Consumables
18th Mar 20204:31 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSAgreement signed with Integumen plc
4th Mar 20207:00 amRNSAppointment of Director
28th Feb 202012:00 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSAgreement signed & EcoWaterOS Consortium
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSDirectorate Change
18th Feb 20205:11 pmRNSHolding(s) in Company
18th Feb 20204:09 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSHolding(s) in Company
14th Feb 20201:00 pmRNSResult of General Meeting
28th Jan 20204:55 pmRNSPosting of Circular and Notice of General Meeting
24th Jan 20208:36 amRNSConditional Placing, Board Changes & Notice of GM
23rd Dec 20195:01 pmRNSCTM Order and Collaboration Agreement
25th Nov 201910:00 amRNSSale of AMBC for Korea Salt Production Facility
9th Oct 20192:38 pmRNSChange of Registered Office
9th Oct 20199:06 amRNSSecond Price Monitoring Extn
9th Oct 20199:00 amRNSPrice Monitoring Extension
8th Oct 20194:41 pmRNSSecond Price Monitoring Extn
8th Oct 20194:35 pmRNSPrice Monitoring Extension
8th Oct 20192:05 pmRNSSecond Price Monitoring Extn
8th Oct 20192:00 pmRNSPrice Monitoring Extension
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20194:35 pmRNSPrice Monitoring Extension
3rd Sep 20192:06 pmRNSSecond Price Monitoring Extn
3rd Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 201911:05 amRNSSecond Price Monitoring Extn
3rd Sep 201911:00 amRNSPrice Monitoring Extension
3rd Sep 20199:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.